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Abstract
Objective To investigate whether centralisation of acute stroke services
in two metropolitan areas of England was associated with changes in
mortality and length of hospital stay.
Design Analysis of difference-in-differences between regions with patient
level data from the hospital episode statistics database linked to mortality
data supplied by the Office for National Statistics.
Setting Acute stroke services in Greater Manchester and London,
England.
Participants 258 915 patients with stroke living in urban areas and
admitted to hospital in January 2008 to March 2012.
Interventions “Hub and spoke” model for acute stroke care. In London
hyperacute care was provided to all patients with stroke. In Greater
Manchester hyperacute care was provided to patients presenting within
four hours of developing symptoms of stroke.
Main outcome measuresMortality from any cause and at any place at
3, 30, and 90 days after hospital admission; length of hospital stay.
Results In London there was a significant decline in risk adjusted
mortality at 3, 30, and 90 days after admission. At 90 days the absolute
reduction was −1.1% (95% confidence interval −2.1 to −0.1; relative
reduction 5%), indicating 168 fewer deaths (95% confidence interval 19
to 316) during the 21 month period after reconfiguration in London. In
both areas there was a significant decline in risk adjusted length of
hospital stay: −2.0 days in Greater Manchester (95% confidence interval
−2.8 to −1.2; 9%) and −1.4 days in London (−2.3 to −0.5; 7%).
Reductions in mortality and length of hospital stay were largely seen
among patients with ischaemic stroke.
Conclusions A centralised model of acute stroke care, in which
hyperacute care is provided to all patients with stroke across an entire
metropolitan area, can reduce mortality and length of hospital stay.
Introduction
Stroke is a leading cause of mortality and disability worldwide.1
Each year in England an estimated 125 000 people have a stroke
and 40 000 of them die.2 Organised inpatient stroke unit care,
which is provided by multidisciplinary teams that exclusively
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manage patients with stroke in a dedicated ward, is associated
with better quality3 and reduced death and dependency.4 The
Department of Health’s National Stroke Strategy for England
recommendedmajor change in the system for stroke, identifying
that care in a stroke unit was the single biggest factor that can
improve outcomes after stroke.5 In several countries acute stroke
services are being centralised as a means of improving access
to organised inpatient stroke unit care. Hospitals of differing
capability work together to create a centralised system of stroke
care6 in which patients are taken to central specialist units rather
than the nearest hospital. Research in the United States,7 8
Canada,9 the Netherlands,10Denmark,11 and Australia12 suggests
this approach can improve provision of evidence based care
processes for patients with stroke—for example, by increasing
access to specialist care and thrombolysis. Other evidence
suggests this approach is highly cost effective.13 While the
improved clinical outcomes associated with organised inpatient
stroke care are well documented, it is unknown if centralising
acute stroke care to a small number of high volume specialist
centres produces better clinical outcomes.14 15 In addition, the
wisdom of focusing on hyperacute stroke care has been
questioned.16
In 2010, acute stroke services were centralised across two
metropolitan areas of England (Greater Manchester, with a
population of 2.68 million, and London, with 8.17 million).17
The changes in both areas entailed the selection of hospitals to
become sites for specialist stroke services in multiple “hub and
spoke” networks during the first 72 hours after stroke (fig 1⇓).
Before the changes in London, 30 hospitals provided acute
stroke care. After centralisation specialist care was provided to
all patients in eight designated hyperacute stroke units 24 hours
a day, seven days a week, with patients being assessed
immediately by specialised stroke medical teams with the
capacity for immediate brain imaging and thrombolysis when
appropriate. Twenty four stroke units were designated to provide
acute rehabilitation services, and eight of these were attached
to a hyperacute stroke unit; five hospitals were no longer to
provide acute stroke services.18 Hospital selection was guided
by a modelling exercise whereby potential sites were identified
based on determination of need, including the travel times
involved, with the intention that no Londoner would be more
than a 30 minute ambulance journey away from the nearest
hyperacute stroke unit.18
In Greater Manchester, the original intention was also to treat
all patients in hyperacute stroke units (one 24/7 comprehensive
stroke centre and two primary stroke centres running 7 am-7
pm, Monday to Friday). Concerns about the number of patients
being transported greater distances, difficulties with repatriation,
and a view that access to specialist stroke centres was purely
for thrombolysis, however, meant that patients presenting only
within four hours of developing stroke symptoms were taken
directly to a comprehensive stroke centre or primary stroke
centre; all other patients were taken to one of 10 district stroke
centres, which were designated to provide all aspects of
post-thrombolysis stroke care.19No hospitals stopped providing
stroke services entirely as a result of the centralisation process
in Greater Manchester.
We investigated the impact of centralising acute stroke services
in these two metropolitan areas on mortality and length of
hospital stay. We used data for all patients in England who had
a stroke during a 51 month period and controlled for trends in
the rest of England during the same period and other factors
that could affect outcomes. The study is part of a larger mixed
methods evaluation.18
Methods
Data
We obtained patient level data from the hospital episode
statistics database20 for all patients in England with a primary
diagnosis of stroke defined with ICD-10 (international
classification of diseases, 10th revision) codes I61 (intracerebral
haemorrhage), I63 (cerebral infarction), or I64 (stroke, not
specified as haemorrhage or infarction) from 1 January 2008 to
31 March 2012. We excluded subarachnoid haemorrhage
(ICD-10 code I60) as it is managed through a different clinical
pathway.21 The data were linked to mortality data supplied by
the Office for National Statistics22 by using an anonymised
unique patient identifier to identify deaths from any cause and
at any place (hospital or otherwise) at 3, 30, and 90 days after
hospital admission. Length of stay was measured in days as the
difference between date of admission and date of discharge,
including same day transfers between hospitals.
We started our analysis period in January 2008, after the
publication of the National Stroke Strategy for the English NHS
in December 2007,5 which was designed to lead to better
emergency responses to stroke and acute stroke care around the
country.23 Our data cover a 27 month period before the changes
in Greater Manchester (which occurred in April 2010), and a
24 month period afterwards. In London they cover a 30 month
period before the changes (July 2010) and a 21 month period
afterwards. In both areas some hospitals began to reconfigure
their services before these dates, and we control for this in our
analysis using hospital and time fixed effects.
Our main analysis was confined to patients living in urban areas
(defined as “urban-less sparse” using the urban/rural
classification for England24: 95% of patients with stroke in
Greater Manchester and London lived in these areas compared
with 75% in the rest of England).We did not restrict the analysis
to any type of hospital (we included hospital fixed effects to
allow for hospital differences), and we did not impose a
minimum number of patients to be treated at each hospital
(observations in the hospital level regressions were weighted
by the number of patients). Over the period of the study, patients
were treated at 11 hospitals in Greater Manchester, 38 in
London, and 405 in the rest of England. Data were available for
258 915 admissions, of which 17 650 were in Greater
Manchester (9413 before reconfiguration, 8237 afterwards) and
33 698 were in London (18 672 and 15 026, respectively).
Statistical analysis
We evaluated whether centralisation of acute stroke services in
Greater Manchester and London had an impact on mortality
and length of hospital stay using regression analysis of
difference-in-differences between regions25 to compare the
changes over time in these areas with the change over time in
the rest of England. The analysis was carried out at hospital
level with quarterly observations of risk adjusted mortality and
length of hospital stay; the risk adjustment was conducted at
the patient level on all patients in the data. The approach is
consistent with Medical Research Council guidelines for using
natural experiments to evaluate population health interventions,26
and a similar method was used in an evaluation of the advancing
quality initiative in the northwest of England.27
We calculated expected risks of death at 3, 30, and 90 days after
admission using patient level logistic regressions, including
binary indicators for sex and age interactions (age measured in
five year bands), stroke diagnosis using the first four digits of
the primary ICD-10 diagnostic code (19 categories), Charlson
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index28 derived from secondary ICD-10 diagnostic codes,
presence of 16 comorbidities included in the Charlson index,
ethnic group (18 categories), deprivation quintile,29 and
urban/rural classification24 (eight categories) of the area in which
the patient lived (of 32 482 lower layer super output areas in
England). We ran the patient level regressions only on patients
who had a stroke before the reorganisations in Greater
Manchester and London so that the risk adjustment was not
contaminated by the changes. The regression coefficients
(derived from the logistic regressions for the period before
implementation) were used to predict the probability of mortality
for every patient (in periods before and after implementation).
These were aggregated to create a dataset of the actual
percentage of patients who died and the expected percentage
by admitting hospital and quarter. We tested whether the
reconfigurations had an impact on mortality using least squares
regression of the actual minus expected mortality percentage
(because we are modelling differences) against interaction terms
betweenGreaterManchester and the period after reconfiguration
and London and the period after reconfiguration. We included
binary indicators for each of the 454 admitting hospitals
(hospital fixed effects) and the 17 quarters (time fixed effects),
and each observation was weighted by the number of patients
treated at that hospital in that quarter. Standard errors were
corrected for heteroskedasticity.
We used the same approach for length of hospital stay but
estimated our risk adjustment equation using a generalised linear
model (GLM) with gamma family and log link to account for
data skewness.30 We experimented with other GLM
specifications and a log transformation but the selected model
gave the best fit in terms of residual plots and Akaike’s
information criterion. We added binary indicators for mortality
at 3, 30, and 90 days after stroke to the risk equation and used
the regression coefficients to predict expected mean length of
hospital stay.
We undertook pre-trends tests to examine whether risk adjusted
mortality and length of hospital stay had a different linear trend
in Greater Manchester and London compared with the rest of
England before the reconfigurations. We reran the models on
every quarter before the reconfigurations and included linear
time trends instead of binary indicators for quarter. We added
interaction terms between Greater Manchester and the linear
time trend and London and the linear time trend and tested the
individual significance of the interaction terms. In every case
they were non-significant (P>0.05).
Results
Patients in Greater Manchester and London were slightly
younger than those in the rest of England, and those in London
were less likely to be white British (table 1⇓). The proportion
of intracerebral haemorrhage strokes was slightly higher in
London than in the rest of England, and slightly lower in Greater
Manchester. Patients in Greater Manchester and London were
less likely to live in deprived areas. Unadjusted outcomes show
a small decline in mortality in London compared with the rest
of England, and a small decline in length of hospital stay in
Greater Manchester and London. There was some evidence of
difference-in-differences with respect to age, sex, type of stroke,
and deprivation in Greater Manchester and age, ethnic group,
and type of stroke in London.
During the study period, risk adjusted mortality and length of
hospital stay fell in Greater Manchester, London, and the rest
of England (fig 2⇓). In London there was a significantly larger
absolute reduction in risk adjusted mortality at three days after
admission than in the rest of England, by −1.0 percentage points
(95% confidence interval −1.5 to −0.4; P<0.001; table 2⇓).
There was also a significantly larger absolute reduction in risk
adjusted mortality at 30 days (−1.3, −2.2 to −0.4; P=0.005) and
90 days after admission (−1.1,−2.1 to −0.1; P=0.03). These
absolute differences represent relative reductions in mortality
of 17%, 7%, and 5%, respectively, which equate to a total
reduction of 146 deaths at three days (95% confidence interval
67 to 225), 194 deaths at 30 days (60 to 328), and 168 deaths
at 90 days (19 to 316) during the 21months after reconfiguration
in London. In Greater Manchester the changes in mortality after
the reconfiguration of services were not significantly different
to the changes seen in the rest of England during the same
period.
In both areas there was a significantly larger decline in risk
adjusted length of hospital stay compared with the rest of
England. There was a significant reduction of −2.0 days (95%
confidence interval −2.8 to −1.2; P<0.001) in Greater
Manchester and −1.4 days (−2.3 to −0.5; P=0.002) in London.
These represent a 9% reduction in length of hospital stay in
Greater Manchester and a 7% reduction in London and imply
17 685 fewer hospital days in Greater Manchester (95%
confidence interval 10 717 to 24 652) and 22 341 fewer in
London (7887 to 36 795) during the periods after reconfiguration
(24 months in Greater Manchester, 21 months in London).
We reran our models on patients stratified by type of stroke and
found that reductions in mortality and length of hospital stay
were achieved largely among patients with ischaemic stroke,
who comprised most cases (68% of the sample) (table 2⇓). Point
estimates of the reductions in mortality in London were higher
for intracerebral haemorrhage than for ischaemic stroke but the
effects for intracerebral haemorrhage were not significant. In
Greater Manchester there was a significant increase in risk
adjusted mortality at 30 days after cerebral infarction, but there
were no significant differences at 3 and 90 days. We reran our
models including 73 558 patients who lived in rural areas, and
this had little impact on the results (table 2).⇓
Discussion
Principal findings
Since the centralisation of acute stroke services in two
metropolitan areas, risk adjusted mortality and length of hospital
stay fell in Greater Manchester, London, and the rest of the
country. In London there was a significant reduction in mortality
at 3, 30, and 90 days after admission over and above the
reduction seen in the rest of England; at 90 days the reduction
in mortality was 1.1 percentage points. There was also a
significant reduction in length of hospital stay of 1.4 days over
and above the reduction seen in the rest of England. In Greater
Manchester there was no impact on mortality over and above
the change seen in the rest of England but there was a significant
reduction in length of hospital stay by 2.0 days. Significant
reductions in mortality and length of hospital stay were largely
achieved among patients with ischaemic stroke.
Strengths and weaknesses
Themain strengths of our study are that we used a large national
dataset containing detailed information on outcomes and patient
characteristics, and the robust quasi-experimental framework;
these allowed us to control for trends in the rest of England and
other factors that could affect outcomes during the same period.
There are, however, several weaknesses. Firstly, the hospital
episode statistics database does not include information on
severity of stroke, which is an important predictor of mortality.31
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Data collected after the reconfigurations from the Stroke
Improvement National Audit Programme32 show that indicators
of stroke severity, such as worst level of consciousness in first
24 hours after stroke and neurological deficits on admission,
varied between Greater Manchester, London, and the rest of
England (see table A, appendix), but there was no discernible
trend over all the indicators. Despite this, and even though our
outcomes are risk adjusted for several patient level factors and
we accounted flexibly for differences between hospitals and
trends over time, we cannot rule out the possibility that the
differences in outcomes could be caused by variations in severity
of stroke between Greater Manchester and London and the rest
of England.
Secondly, we were unable to assess the impact of the
reconfigurations on other outcomes, such as quality of life,
disability, or neurological and functional impairment, as these
measures were not collected in the hospital episode statistics
database. We could, however, investigate the impact of the
reconfigurations on mortality and length of hospital stay,
outcomes that have not been previously reported.
Thirdly, the hospital episode statistics database includes only
patients admitted to hospital. It does not include any information
about patients who died before they reached the hospital, nor
does it include information on the time of stroke; hence our
analyses of mortality were based on time from admission. If
patients with stroke in London were more likely to die before
reaching the hospital because of longer travel distances to
hyperacute stroke units then the effects of the reconfigurations
on mortality would be overestimated. Evidence suggests this is
unlikely because ambulance journey times for patients with
stroke did not increase appreciably after the reconfiguration in
London, with mean times from scene to hospital of 14 minutes
from January 2005 to March 20083 and 16 minutes from April
2011 to March 2012.33 Also, severity of stroke in London after
reconfiguration was similar to the severity in the rest of England
(table A, appendix); if more patients with severe stroke died in
London before reaching the hospital the level of severity in the
audit data for London would be lower than elsewhere.
Fourthly, length of hospital stay was measured as the difference
between date of admission and date of discharge. We assumed
that when patients were discharged from one hospital and
readmitted to another hospital on the same day this was a
transfer related to the original stroke, capturing the movement
between components of the stroke care pathway (for example,
between a hyperacute stroke unit and a stroke unit in London).
Conversely, we assumed that when a subsequent admission
occurred one or more days later after discharge this was a
recurrent stroke (the risk of recurrence of stroke in the first
month after discharge is 1.1-15%).34
Finally, there was a higher than expected number of patients
with stroke per month in London during the period after
reconfiguration. One possible reason is that after the
reconfiguration London units treated more patients from
surrounding areas, who might previously have gone to their
local emergency department. This could bias the results in favour
of the London reconfiguration if the additional admissions were
for less severe strokes, but there are no discernible differences
in severity between London, Greater Manchester, and the rest
of England (table A, appendix).
Comparison with other studies
Our findings with respect to mortality in London are consistent
with a cost effectiveness analysis of the reconfiguration of acute
stroke services in London,13 which also found a significant
improvement in survival in London at 90 days after admission.
In that study the impact on survival was calculated with survival
models estimated before and after the reconfiguration and an
adjustment was applied to the difference in survival to account
for national trends in mortality. Our study had a larger sample
size, used national individual level data, had more patients in
the period after reconfiguration in London, provides a more
robust treatment of national trends via the quasi-experimental
difference-in-difference design, and also examined the
reconfiguration in Greater Manchester. Our findings are also
consistent with a previous analysis based on national stroke
audit data showing that patients admitted to stroke services with
higher levels of organisation were more likely to receive high
quality care and to have a reduced risk of death 30 days after
stroke.3
Implications
In London hyperacute stroke care was available to all patients,
while in Greater Manchester it was available only to patients
presenting within four hours of developing stroke symptoms.
Our findings show that mortality outcomes were different in
the two systems. In London, ambulance data indicate that in
2011-12, 98.7% of patients with stroke were transported to the
appropriate service: 95.7% were taken appropriately to a
hyperacute stroke unit; 3% were taken appropriately to an
emergency department; and 1.3% were taken to an emergency
department when they should have been taken to a hyperacute
stroke unit.33 A review of the first year of the new model in
Greater Manchester reported that of the patients who presented
with stroke within four hours, 36% were not taken to a
comprehensive stroke centre or primary stroke centre.19 Hence,
a higher proportion of patients than planned were admitted to
district hospitals, where access to specialist expertise and care
was more limited.
In addition, data on the achievement of processes measuring
the quality of care that patients with stroke receive during the
first 72 hours of care were collected between April 2011 and
December 2012 as part of the Stroke Improvement National
Audit Programme in England.32A significantly higher proportion
of patients in London received care that was compliant with the
care processes compared with in Greater Manchester and the
rest of England (which were broadly similar) (table B,
appendix). This suggests that the centralised model of care in
London was more closely adhered to and achieved greater
compliance with care processes. There is evidence that better
compliance with these measures is negatively correlated with
mortality.3According to themultivariate analyses thesemeasures
independently affect mortality,3 suggesting that different aspects
of specialist care provided throughout the hyperacute stroke
unit can separately affect patient outcomes. The upshot is that
differences in mortality can be explained by the lower level of
adherence in Greater Manchester or by differences between the
two systems in terms of the access to hyperacute care for patients
presenting after four hours of developing symptoms of stroke.
This suggests that the type of system redesign and the extent of
its implementation can affect patient outcomes and needs to be
taken into account by those who are reorganising services.
Additionally, while there is evidence that organised inpatient
stroke care is beneficial to patients with intracerebral
haemorrhage as well as ischaemic stroke,15 the improvements
in outcomes from centralisation that we found in our study were
largely among patients with ischaemic stroke. This could reflect
the poorer prognosis in patients with intracerebral
haemorrhage.35
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In London we found some evidence that mortality was reduced
at three days, suggesting that the reconfiguration might have
delayed death among these patients but did not change the
ultimate outcome. Alternatively, as point estimates of the
reductions in mortality in London were higher for intracerebral
haemorrhage than for ischaemic stroke but the effects were not
significant, the wider confidence intervals might be because of
the smaller numbers of patients in the data with this type of
stroke.
On a different point, while the results were consistent when we
included patients living in rural areas, theymight be less relevant
to services in rural settings. The greater travel times in rural
areas make centralisation challenging and might necessitate
other solutions, such as telemedicine, whereby consultation and
triage can be conducted remotely by a stroke physician in a
specialist stroke unit.36-38 Finally, our findings could also inform
the centralisation of other healthcare services such as cancer
care,39 cardiovascular care,40 major trauma care,41 and vascular
surgery.42 Similar models of care adapted to local need could
be applied to other large metropolitan areas and to other
conditions.
Future research would be beneficial to examine the impact of
centralising acute stroke services on disability after stroke and
also on achievement of care processes and quality of care.
Further information on the cost and cost effectiveness of
centralisation would also be useful for policy makers and
commissioners.
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Tables
Table 1| Characteristics of patients before and after reconfiguration of acute stroke services in Greater Manchester and London compared
with rest of England
Difference-in-differences*LondonGreater ManchesterRest of England
London
minus rest
of England
Manchester
minus rest
of EnglandDifference
After
(n=15
026)
Before
(n=18
672)Difference
After
(n=8237)
Before
(n=9413)Difference
After
(n=85
483)
Before
(n=122
084)
Unadjusted outcomes
Unadjusted mortality:
−0.30.2−1.24.65.8−0.75.66.3−0.95.76.6At 3 days (%)
−0.40.7−2.814.116.8−1.616.518.1−2.416.919.2At 30 days (%)
−0.4−0.2−3.619.423.0−3.321.925.2−3.122.725.8At 90 days (%)
−0.2−1.4−2.817.820.6−4.017.721.7−2.618.421.0Mean
unadjusted
length of
hospital stay
(days)
Patient characteristics
Age (year):
0.5−0.10.273.373.0−0.473.974.3−0.375.375.6Mean
1.4−1.10.154.454.3−2.453.656.0−1.359.360.6≥75 (%)
−0.4−1.4−1.249.851.0−2.150.452.6−0.852.253.0Female (%)
−5.6−0.9−3.555.058.51.284.282.92.186.484.3White British
ethnic group
(%)
−0.70.3−0.914.815.70.211.711.5−0.212.712.8Intracerebral
haemorrhage
(%)†
0.7−3.77.276.168.92.864.461.66.571.665.1Cerebral
infarction (%)‡
0.03.3−6.39.115.4−3.023.926.9−6.315.722.1Stroke, not
specified as
haemorrhage or
infarction (%)§
0.00.00.02.02.00.02.02.00.01.91.9Charlson index
(mean score)
0.21.50.613.212.61.910.38.40.417.617.2Most deprived
fifth (%)¶
*Unadjusted difference-in-differences between regions showing change over time in Greater Manchester and London minus change over time in rest of England.
†Primary diagnosis of stroke with ICD-10 diagnostic code I61.
‡Primary diagnosis of stroke with ICD-10 diagnostic code I63.
§Primary diagnosis of stroke with ICD-10 diagnostic code I64.
¶Based on 32 482 small areas (lower layer super output areas) of residence in England.
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Table 2| Absolute differences in risk adjusted mortality and length of hospital stay between Greater Manchester and London compared
with rest of England before and after reconfiguration of acute stroke services
Difference-in-differences* (95% CI), P value
London minus rest of EnglandGreater Manchester minus rest of England
All stroke types combined; patients living in urban areas only
Risk adjusted mortality:
−1.0 (−1.5 to −0.4), <0.001−0.04 (−0.7 to 0.6), 0.90At 3 days
−1.3 (−2.2 to −0.4), 0.0050.8 (−0.3 to 1.9), 0.15At 30 days
−1.1 (−2.1 to −0.1), 0.030.1 (−1.1 to 1.3), 0.89At 90 days
−1.4 (−2.3 to −0.5), 0.002−2.0 (−2.8 to −1.2), <0.001Risk adjusted length of hospital stay (days)
Intracerebral haemorrhage†; patients living in urban areas only
Risk adjusted mortality:
−3.3 (−5.7 to −0.9), 0.0060.4 (−2.9 to 3.8), 0.80At 3 days
−2.0 (−4.8 to 0.8), 0.16−1.1 (−5.1 to 2.9), 0.60At 30 days
−1.1 (−4.0 to 1.7), 0.440.3 (−4.3 to 3.8), 0.90At 90 days
−0.7 (−2.4 to 0.9), 0.39−1.3 (−3.7 to 1.0), 0.27Risk adjusted length of hospital stay (days)
Cerebral infarction‡; patients living in urban areas only
Risk adjusted mortality:
−0.8 (−1.2 to −0.3), 0.0010.5 (−0.2 to 1.1), 0.14At 3 days
−1.3 (−2.2 to −0.3), 0.011.9 (0.6 to 3.2), 0.004At 30 days
−1.1 (−2.2 to −0.03), 0.041.1 (−0.4 to 2.5), 0.14At 90 days
−1.4 (−2.4 to −0.3), 0.009−2.6 (−3.6 to −1.5), <0.001Risk adjusted length of hospital stay (days)
Stroke, not specified as haemorrhage or infarction§; patients living in urban areas only
Risk adjusted mortality:
0.02 (−2.0 to 2.0), 0.98−0.8 (−2.5 to 0.9), 0.34At 3 days
−1.3 (−4.3 to 1.7), 0.40−0.1 (−2.6 to 2.4), 0.94At 30 days
−2.2 (−5.4 to 1.0), 0.18−1.2 (−3.9 to 1.5), 0.39At 90 days
−2.2 (−3.7 to −0.7), 0.004−0.9 (−2.4 to 0.5), 0.21Risk adjusted length of hospital stay (days)
All stroke types combined; patients living in urban and rural areas
Risk adjusted mortality:
−1.0 (−1.5 to −0.4), 0.001−0.1 (−0.7 to 0.6), 0.94At 3 days
−1.2 (−2.1 to −0.2), 0.010.8 (−0.2 to 1.9), 0.13At 30 days
−1.0 (−2.0 to −0.1), 0.040.1 (−1.2 to 1.4), 0.87At 90 days
−1.4 (−2.3 to −0.5), 0.003−2.1 (−2.9 to −1.3), <0.001Risk adjusted length of hospital stay (days)
*Values are risk adjusted difference-in-differences between regions showing change over time in Greater Manchester and London minus change over time in rest
of England.
†Primary diagnosis of stroke with ICD-10 diagnostic code I61.
‡Primary diagnosis of stroke with ICD-10 diagnostic code I63.
§Primary diagnosis of stroke with ICD-10 diagnostic code I64.
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Figures
Fig 1 Summary of acute stroke pathway in Greater Manchester and London before and after reconfiguration of acute stroke
services. ASU=acute stroke unit, CSC=comprehensive stroke centre, PSC=primary stroke centre, DSC=district stroke
centre. Before the centralisation of acute stroke services in both Greater Manchester and London, patients with suspected
stroke were taken to the nearest emergency department to receive stroke care. They were then sent to either an acute
stroke unit or a regular hospital ward for treatment before being discharged for community rehabilitation. After the
reorganisation in Greater Manchester patients presenting within four hours of developing stroke symptoms are sent to the
comprehensive stroke centre or a primary stroke centre for hyperacute care. Once stable, they are repatriated to a district
stroke centre, a nursing home, or their own home for community rehabilitation. Patients presenting outside the four-hour
window are taken to the nearest DSC, receiving similar treatment to that provided before the reorganisation. After the
reorganisation in London, patients presenting with stroke symptoms at any time are taken to a hyperacute stroke unit for
assessment and treatment, then repatriated to a stroke Unit, to a nursing home, or to their own home for community
rehabilitation
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Fig 2 Risk adjusted mortality at 3, 30, and 90 days and length of hospital stay in Greater Manchester, London, and the rest
of England by quarter. Differences between actual mortality and length of hospital stay and expected values derived from
patient level risk equations are shown. In both areas some hospitals began to reconfigure their services before these dates;
this is controlled for by using hospital and time fixed effects
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